Which Factors Will Push The Follicle Stimulating Hormone Market To Achieve $2.59 Billion By 2029?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
#How Will The Follicle Stimulating Hormone Market Valuation Change Between Now And 2029?#_x000D_
In recent times, the follicle stimulating hormone market has experienced consistent growth. The market size is expected to increase from $2.03 billion in 2024 to $2.12 billion in 2025, representing a compound annual growth rate (CAGR) of 4.4%. The historical growth trends in this market can be linked to a surge in hormonal disorder cases, an escalated demand for fertility treatments, the broadening of FSH indications, the introduction of new FSH products into the market, and a heightened demand for secure and efficient contraceptive methods._x000D_
_x000D_
The market size of the follicle-stimulating hormone is projected to witness a significant uptick in the coming years. It is anticipated to escalate to “$2.59 billion by 2029, recording a compound annual growth rate (CAGR) of 5.2%. The expansion during the projection period is due to a range of factors like the broadening of therapeutic applications, an increasing requirement for combination therapy, a surge in demand for effective contraceptive choices, the aging demographic and associated healthcare needs, and market growth in crucial areas. Notable trends during this forecast period incorporate the advent of sophisticated biosimilar FSH products, received regulatory endorsements and market accessibility, technological leaps in the manufacture and delivery of FSH, as well as the mounting need for potent contraceptive alternatives._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp_x000D_
_x000D_
#What Underlying Factors Are Supporting The Follicle Stimulating Hormone Market Growth?#_x000D_
The growth of the follicle-stimulating hormone market is anticipated to be fueled by the escalating incidence of infertility. Infertility is a condition that impacts the reproductive system of either males or females, marked by the inability to get pregnant even after a year or more of regular unprotected sexual encounters. The hormone known as follicle-stimulating spurs the development of eggs in the female ovaries and helps manage the menstrual cycle. In males, it enhances testicular growth and aids in the creation of a crucial protein for male fertility by stimulating the growth of healthy sperm cells. For example, the World Health Organization, a specialized United Nations agency based in Switzerland, reported in April 2023 that approximately one in every six adults worldwide, or about 17.5% of the adult population, were affected by infertility. Additionally, the Australian Bureau of Statistics, an Australian independent constitutional body responsible for collecting and studying data and advising the national, state, and territory governments on facts, noted in October 2023 that there were 300,684 births registered in 2022, marking a 3% decrease from 2021. The total fertility rate for Australian women was recorded as 1.63 births per woman. Hence, the rising incidence of infertility is leading to the expansion of the follicle-stimulating hormone market._x000D_
_x000D_
#What Is The Segment Breakdown Of The Follicle Stimulating Hormone Market?#_x000D_
The follicle stimulating hormone market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Recombinant FSH, Urinary FSH_x000D_
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications_x000D_
3) By End-Users: Infertility Center, Hospitals, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations _x000D_
2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones _x000D_
_x000D_
#How Are Global Trends Impacting The Development Of The Follicle Stimulating Hormone Market?#_x000D_
A significant trend that is growing in popularity in the follicle-stimulating hormone market is the introduction of novel products. Major corporations in this market are concentrating on the development of inventive products to consolidate their market position. Take for example Proov, a women’s health firm based in the United States, which launched the Proov Empower Perimenopause Testing System in July 2024. The Proov Empower system delivers extensive and customized information about how a woman’s hormonal fluctuations impact her health and wellness. This urine test, which is non-invasive and can be administered multiple times, gauges four essential hormones – FSH, Estrogen marker E1G, Progesterone marker PdG, and LH – all of which shape symptoms and perimenopause experiences. Proov Empower accommodates for repeated testing, helping women monitor hormonal changes and symptoms, thus proving to be an important aid during the menopause transition._x000D_
_x000D_
#Which Firms Are Driving Innovation Within The Follicle Stimulating Hormone Market?#_x000D_
Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem’s life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd. _x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
_x000D_
#Which Region Is Likely To Register The Fastest Growth In The Follicle Stimulating Hormone Market?#_x000D_
North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=12486&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
